ZYUS Life Sciences Corporation (ZYUS) Sets Sept. 30 for Phase 2a Topline Data

ZYUS Life Sciences expects to announce topline Phase 2a UTOPIA-1 results on Sept. 30, 2026, and named Wayne Brownlee Audit Committee Chair while John L. Knowles serves as Interim CFO.Material DetailsContext by AI AnalystZYUS is a clinical-stage company; this is an early catalyst where data quality…